Correlation Between Spyre Therapeutics and Titan International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Titan International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Titan International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Titan International, you can compare the effects of market volatilities on Spyre Therapeutics and Titan International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Titan International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Titan International.

Diversification Opportunities for Spyre Therapeutics and Titan International

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Spyre and Titan is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Titan International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Titan International and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Titan International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Titan International has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Titan International go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Titan International

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 5.38 times more return on investment than Titan International. However, Spyre Therapeutics is 5.38 times more volatile than Titan International. It trades about 0.05 of its potential returns per unit of risk. Titan International is currently generating about -0.03 per unit of risk. If you would invest  975.00  in Spyre Therapeutics on September 3, 2024 and sell it today you would earn a total of  1,868  from holding Spyre Therapeutics or generate 191.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  Titan International

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Titan International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Titan International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Titan International is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Spyre Therapeutics and Titan International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and Titan International

The main advantage of trading using opposite Spyre Therapeutics and Titan International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Titan International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan International will offset losses from the drop in Titan International's long position.
The idea behind Spyre Therapeutics and Titan International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios